Diabetes Mellitus: all 11,090 studies
Page 94 of 111. Open to participants first (1,319), then studies with results posted, then the rest; newest registration first within each.
- Endothelial Dysfunction and DiabetesCompletedNCT01097551
- Vascular Effects of Sitagliptin in Diabetes MellitusStatus unknownNCT01096277Phase 4
- Investigate the Effect of AZD1656 on the Pharmacokinetics of Sitagliptin in Patients With Type 2 Diabetes MellitusCompletedNCT01095991Phase 1
- Nutrition Education Intervention in Adults With Type 2 Diabetes Mellitus in a Resource Poor SettingCompletedNCT01095965Not applicable
- Effects of Valsartan and Aliskiren on Hemostatic Indices in Hypertensive DiabeticsStatus unknownNCT01095822Phase 4
- Abnormal Structure and Bone Density in DiabetesCompletedNCT01094899Not applicable
- Electrodiagnostic Parameters in Patients With Impaired Glucose Tolerance and Diabetes MellitusCompletedNCT01094418
- Insulin Secretion and AdvagrafCompletedNCT01092806Phase 4
- Post-extraction Wound Healing in Patients With Type 2 DiabetesCompletedNCT01091909Not applicable
- Comparing Two Different Approaches in the Screening of Cystic Fibrosis Related DiabetesCompletedNCT01091025Not applicable
- Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus Receiving Background Treatment With Glimepiride Alone or in Combination With Metformin or With Pioglitazone AloneTerminatedNCT01089790Phase 3
- Joint Application of Human Insulin and Rapid Insulin Analogue in Control of Postprandial GlycemiaStatus unknownNCT01088451Not applicable
- The Influence of Adalimumab on Cardiovascular and Metabolic Risk in PsoriasisStatus unknownNCT01088165Phase 4
- Metformin Versus Insulin in the Treatment of Gestational Diabetes MellitusCompletedNCT01087866Phase 2/3
- A Two Part Trial Investigating the Safety of NN9925 in Healthy Male SubjectsCompletedNCT01087645Phase 1
- Clinical Trail of Tang-min-Ling Pills in Type 2 Diabetes MellitusStatus unknownNCT01087242Phase 3
- Improving Diabetes Care and Outcomes on the South Side of ChicagoCompletedNCT01087073Not applicable
- Risk of Hospitalization for Severe Hypersensitivity (Including Severe Skin Reactions) in Patients With Type 2 Diabetes Exposed to Oral Antidiabetic TreatmentsCompletedNCT01086319
- Risk of Hospitalized Infections Among Patients With Type 2 Diabetes Exposed to Oral Antidiabetic TreatmentCompletedNCT01086306
- Risk of Acute Liver Failure Among Patients With Type 2 Diabetes Exposed to Oral Antidiabetic TreatmentsCompletedNCT01086293
- Risk of Cardiovascular Events in Patients With Type 2 Diabetes Initiating Oral Antidiabetic TreatmentsCompletedNCT01086280
- The Effect of a Gastric Bypass on Type 2 Diabetes in the Morbidly Obese PatientCompletedNCT01086111
- Effects of Nordic Walking and Exercise on Glucose Metabolism in Type 2 Diabetes Mellitus: A Randomized Controlled TrialCompletedNCT01085773Phase 2
- NOX-E36 Multiple Ascending Dose Study in Healthy Volunteers and Patients With Type 2 Diabetes MellitusCompletedNCT01085292Phase 1/2
- A Culturally Tailored Lifestyle Intervention to Prevent Diabetes in South AsiansCompletedNCT01084928Not applicable
- Corneal Endothelium Morphology and Central Thickness in Type II Diabetes Mellitus and Normal SubjectsStatus unknownNCT01084850
- To Evaluate the Effect of Gemfibrozil on the Pharmacokinetics and Pharmacodynamics of a Single Dose of AZD1656CompletedNCT01083212Phase 1
- Effects of Caloric Restriction Alone Versus Postoperative Caloric Restriction Following Bariatric Surgery on Glucose Metabolism in Patients With Diabetes MellitusTerminatedNCT01083108Phase 2
- Investigate the Effect of AZD1656 on the Pharmacokinetics of Pioglitazone and Vice Versa in Type 2 Diabetes MellitusCompletedNCT01082120Phase 1
- Insulin Glargine for Diabetes Metabolism(DM)Type II Patients Under Enteral NutritionTerminatedNCT01081938Phase 4
- Evaluation of a Noninvasive Diabetes Screening Device in Subjects at Risk for DiabetesCompletedNCT01080157
- Midfoot Fusion Bolt (MFB) in the Early Stage of Diabetic-neuropathic Charcot FeetTerminatedNCT01079637Not applicable
- Clinical Trial of SB-509 in Subjects With Diabetic NeuropathyCompletedNCT01079325Phase 2
- Corneal Endothelial Changes Associated With Phacoemulsification in Diabetes Mellitus Type IICompletedNCT01078103
- An Observational Study Investigating the Safety and Effectiveness of Repaglinide in Chinese PatientsCompletedNCT01077570
- Efficacy Evaluation of Different Medication Combination in Type 2 Diabetes TreatmentCompletedNCT01076842Phase 4
- Effects of a Spiced Meat Patty on Inflammation in Men With Type 2 DiabetesCompletedNCT01076829Not applicable
- Comparison of Two NN1250 Formulations in Subjects With Type 1 DiabetesCompletedNCT01076634Phase 1
- Cohort Study in Type 2 Diabetes in ChinaStatus unknownNCT01076023
- The Impact of a Video Cell Phone Reminder System on Glycemic Control in Patients With Diabetes MellitusStatus unknownNCT01075997Not applicable
- Closing the Loop for 36 Hours in Adolescents With Type 1 DiabetesCompletedNCT01074801Phase 2
- Randomised Controlled Trial of Structured Personal Care of Type 2 Diabetes MellitusCompletedNCT01074762Not applicable
- Challenging the Gold Standard: Pilot Study Comparing Continuous Glucose Monitoring System (CGMS), Capillary Glucose Monitors and 3 Hour Glucose Tolerance Test (GTT) to Diagnose Gestational Diabetes Mellitus (GDM)CompletedNCT01074489
- A Study to Evaluate the Effect of ASP1941 in Adult Patients With Type 2 Diabetes MellitusCompletedNCT01071850Phase 2
- Dietetic Intervention With Soluble Fiber in Type 2 Diabetes Mellitus (DM) Patients With Metabolic Syndrome (MS)CompletedNCT01071785Not applicable
- Metabolic Response of Slow Released Carbohydrates in Diabetes MellitusCompletedNCT01070238Phase 1/2
- Safety and Efficacy of BGP-15 in Patients With Type 2 Diabetes MellitusTerminatedNCT01069965Phase 2
- To Assess the Pharmacokinetics of AZD1656 and Its Metabolite in Type 2 Diabetes Mellitus PatientsCompletedNCT01069926Phase 1
- Association of AGTR1 and ACACB Gene Polymorphism and Diabetic Nephropathy in Type 2 DiabetesCompletedNCT01069549
- Alternative Delivery of Dose Adjustment For Normal Eating (DAFNE) Trial in Patients With Type 1 DiabetesCompletedNCT01069393Not applicable
- Treatment of Patients With Newly Onset of Type 1 Diabetes With Mesenchymal Stem CellsCompletedNCT01068951Not applicable
- Low Glycemic Load Diets in Latino Children at Risk for Type 2 DiabetesCompletedNCT01068197Phase 2/3
- Self-Management and Resourceful Transition of Type 2 Diabetes With Stage 3 Kidney DiseaseTerminatedNCT01067963Not applicable
- Motivational Interviewing to Promote Maintenance of Physical Activity in People With Type 2 DiabetesCompletedNCT01067924Not applicable
- A Randomized Control Trial Comparing Linjeta Versus Humalog in Pumps: Effect on Postprandial Blood Sugars.WithdrawnNCT01067118Phase 2
- Safety and Efficacy of XOMA 052 in Subjects With Type 2 Diabetes Mellitus on Stable Metformin MonotherapyCompletedNCT01066715Phase 2
- Psychosocial Treatment Intervention in Persons Newly Diagnosed With Rheumatoid Arthritis or DiabetesCompletedNCT01066130Not applicable
- A Study to Evaluate the Efficacy and Safety of PPB-R-203-Based Meal Versus TK9-Based Meal in 20 Patients With DiabetesStatus unknownNCT01065402Not applicable
- Efficacy Of Autologous Bone Marrow Derived Stem Cell Transplantation In Patients With Type 2 Diabetes Mellitus-2CompletedNCT01065298
- Pharmacokinetics/Dynamics of Basal (Continuous) Insulin Infusion Administered Either Intradermally or SubcutaneouslyCompletedNCT01061216Phase 1/2
- The Effect of Prostaglandin I2 on the Endothelial Cell Function Disorder in Type 2 Diabetes Mellitus PatientsCompletedNCT01061060Phase 4
- Glucose Clamp Study to Prove Hypo- and Hyperglycemic Episodes Using a Non-invasive Glucose Monitoring DeviceCompletedNCT01060917Phase 1/2
- Effect of Internet Therapeutic Intervention on A1C Levels in Type 2 Diabetes Mellitus (DM) on Combination Oral TherapySuspendedNCT01060241Not applicable
- Tele-Diab: Electronic Diary for Patients With Type 2 Diabetes MellitusStatus unknownNCT01058889Phase 3
- Gestational Diabetes: Induction Versus Expectant Management of LabourCompletedNCT01058772Not applicable
- Semi-automatic Response System(SARS)in Type 2 DiabetesCompletedNCT01058733Not applicable
- Changes in Serum Electrolytes at Different Glucose Concentrations + Impact on a Non-invasive Glucose Monitoring MethodCompletedNCT01058577Phase 1
- A Study to Assess the Efficacy and Safety of ASP1941 in Japanese Type 2 Diabetes PatientsCompletedNCT01057628Phase 3
- Resistant Hypertension in Patients With Type-II-Diabetes MellitusCompletedNCT01056367
- Observational Study in Japanese Type 2 Diabetes PatientsCompletedNCT01055808
- Drug-drug Interaction Study of Dapagliflozin With Voglibose in Japanese Type 2 Diabetes Mellitus PatientsCompletedNCT01055652Phase 1
- New Body Mass Index (BMI) Cut-offs for the Diagnosis of Obesity and ComorbiditiesStatus unknownNCT01055626
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Doses of JNJ-38431055, Sitagliptin, and Co-administration of JNJ-38431055 and SitagliptinCompletedNCT01054118Phase 1
- A Study to Assess the Long-term Safety and Efficacy of ASP1941 in Japanese Diabetic PatientsCompletedNCT01054092Phase 3
- Phase II Pharmacodynamic Trial to Determine the Effects of Bardoxolone Methyl on eGFR in Patients With Type 2 Diabetes and Chronic Kidney DiseaseCompletedNCT01053936Phase 2
- Qingdao Diabetes Prevention ProjectCompletedNCT01053195Not applicable
- Curcumin Therapy in Patients With Impaired Glucose Tolerance and Insulin ResistanceStatus unknownNCT01052025Phase 4
- A Care Model for Hip-fractured Elderly Persons With Diabetes MellitusCompletedNCT01051830Not applicable
- Effectiveness of a High-risk Diabetic Patients ProgramCompletedNCT01051245Not applicable
- Effect of NN5401 in Japanese Subjects With Type 1 DiabetesCompletedNCT01051102Phase 1
- Effects of Lifestyle Modification on Metabolic Parameters in Type 2 Diabetic PatientsStatus unknownNCT01051089Not applicable
- A Study to Compare Taspoglutide and Insulin Glargine in Insulin-Naïve Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin and Sulfonylurea Combination TherapyTerminatedNCT01051011Phase 3
- Effectiveness of the Farsi Diabetes Self-management Education (FDSME) Program for People With Type 2 DiabetesCompletedNCT01050803Not applicable
- Cardiovascular Risk Factors in Patients With Diabetes -a Prospective Study in Primary CareCompletedNCT01049737
- Glucose-dependent Insulinotropic Polypeptide - New Role as Blood Glucose Stabilizer?CompletedNCT01048268Phase 1/2
- The Effects of High and Low GI Breakfasts on Cognitive Performance in Adults With Type 2 DiabetesStatus unknownNCT01047813
- The TRIABETES - ARMMS-T2D Study: A Randomized Trial to Compare Surgical and Medical Treatments for Type 2 DiabetesActive, not recruitingNCT01047735Not applicable
- Prospective Controlled Trial on Surgical Treatment of Type 2 Diabetes Patients With BMI 25-30 by Means of Biliopancreatic DiversionStatus unknownNCT01046994Phase 3
- Safety Study of BMS-770767 in Subjects With Type 2 DiabetesCompletedNCT01046422Phase 2
- A Study of OPC-262 in Patients With Type 2 DiabetesCompletedNCT01046318Phase 3
- A Study of the Rules for Insulin Dosing in Patients Using Multiple Daily InjectionsStatus unknownNCT01045954Not applicable
- Glibenclamide (Dose to be Titrated From Starting Dose of 5mg om) Plus Rosiglitazone 4mg om (Increased to 8mg om After 6 Months) and vs Glibenclamide (Dose to be Titrated With Starting Dose of 5mg om) Plus Placebo, Administered to Patients With Type 2 Diabetes MellitusCompletedNCT01045590Phase 4
- Metabolic Surgery Versus Medical Management for Resolution of Type II DiabetesCompletedNCT01044602Not applicable
- Effect of Internet Therapeutic Intervention on A1C Levels in Type 2 Diabetes Mellitus (DM) on MonotherapySuspendedNCT01044368Not applicable
- A Study of Single Doses of RO4998452 in Patients With Type 2 DiabetesCompletedNCT01044017Phase 1
- Myocardial Perfusion in Type 2 DiabetesCompletedNCT01043965Phase 1/2
- The Effect of NN1250 in Subjects With Type 2 Diabetes of Different Race and/or Ethnic OriginCompletedNCT01043510Phase 1
- A Study of Aleglitazar in Type 2 Diabetes Patients With Moderate Renal ImpairmentCompletedNCT01043029Phase 2
- A Study With Aleglitazar in Patients With a Recent Acute Coronary Syndrome and Type 2 Diabetes MellitusCompletedNCT01042769Phase 3
- Profiling of Original Cellular and Humoral Biomarkers of Type 1 DiabetesCompletedNCT01042301Not applicable